These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8446679)
1. Different effects of methylxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model. Kitatani T; Watanabe Y; Shibuya T Pharmacol Biochem Behav; 1993 Feb; 44(2):457-61. PubMed ID: 8446679 [TBL] [Abstract][Full Text] [Related]
2. [Effects of pentoxifylline on 5-hydroxytryptamine in the mouse brain]. Kitatani T; Hayashi S; Sakaguchi T Nihon Yakurigaku Zasshi; 1985 Nov; 86(5):353-8. PubMed ID: 2417922 [TBL] [Abstract][Full Text] [Related]
3. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine. Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387 [TBL] [Abstract][Full Text] [Related]
4. Effects of paroxetine on 5-HT-induced head twitches and phosphatidylinositol hydrolysis in mice. Marshall EF; Milne J; Dodds SM Neuroreport; 1992 Nov; 3(11):1009-12. PubMed ID: 1482758 [TBL] [Abstract][Full Text] [Related]
5. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814 [TBL] [Abstract][Full Text] [Related]
6. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. Trulson ME; Eubanks EE; Jacobs BL J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525 [TBL] [Abstract][Full Text] [Related]
7. Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells. Janitschke D; Lauer AA; Bachmann CM; Seyfried M; Grimm HS; Hartmann T; Grimm MOW Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260941 [TBL] [Abstract][Full Text] [Related]
8. Potentiating effects of methylxanthines on teratogenicity of mitomycin C in mice. Nakatsuka T; Hanada S; Fujii T Teratology; 1983 Oct; 28(2):243-7. PubMed ID: 6417813 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of the behavioral toxicity induced by combined administration of ethanol with methylxanthines: evaluation by discrete avoidance in mice. Kuribara H J Toxicol Sci; 1993 May; 18(2):95-101. PubMed ID: 8331697 [TBL] [Abstract][Full Text] [Related]
10. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Darmani NA; Johnson JC Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052 [TBL] [Abstract][Full Text] [Related]
11. Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome. Ortmann R; Martin S; Radeke E; Delini-Stula A Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):225-30. PubMed ID: 6114439 [TBL] [Abstract][Full Text] [Related]
12. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan. Pranzatelli MR; Dollison AM; Hlibczuk V Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568 [TBL] [Abstract][Full Text] [Related]
13. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests. Eide PK; Hole K; Berge OG; Broch OJ Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956 [TBL] [Abstract][Full Text] [Related]
15. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine. Colpaert FC; Koek W; Lategan A Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211 [TBL] [Abstract][Full Text] [Related]
16. A possible mechanism of the tyramine-induced head-twitch response. Orikasa S; Kisara K Eur J Pharmacol; 1982 May; 80(2-3):163-9. PubMed ID: 6213417 [TBL] [Abstract][Full Text] [Related]
17. Caffeine, theophylline, theobromine, and developmental growth of the mouse mammary gland. VanderPloeg LC; Wolfrom DM; Rao AR; Braselton WE; Welsch CW J Environ Pathol Toxicol Oncol; 1992; 11(3):177-89. PubMed ID: 1625188 [TBL] [Abstract][Full Text] [Related]
18. Increased behavioural response to intrathecal serotonin after lesion of serotonergic pathways with 5,7-dihydroxytryptamine seems not to be due to depletion of serotonin. Eide PK; Hole K Acta Physiol Scand; 1988 Oct; 134(2):291-4. PubMed ID: 2976239 [TBL] [Abstract][Full Text] [Related]
19. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine. Breese GR; Vogel RA; Mueller RA J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057 [TBL] [Abstract][Full Text] [Related]
20. Inherent differences in sensitivity to methylxanthines among inbred mice. Logan L; Seale TW; Carney JM Pharmacol Biochem Behav; 1986 May; 24(5):1281-6. PubMed ID: 3725830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]